{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:08:01Z","timestamp":1790460481982,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["101679"],"award-info":[{"award-number":["101679"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Validated diagnostic tools that are accurate, cost effective and acceptable to patients are required for disease stratification and monitoring in <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To investigate the performance and cost of multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content> alongside existing biomarkers in the assessment of <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adult patients undergoing standard of care liver biopsy for <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content> were prospectively recruited at two <jats:styled-content style=\"fixed-case\">UK<\/jats:styled-content> liver centres and underwent multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>, blood sampling and transient elastography withing 2\u00a0weeks of liver biopsy. Non\u2010invasive markers were compared to histology as the gold standard.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data were obtained in 50 patients and 6 healthy volunteers. Corrected T1 (<jats:styled-content style=\"fixed-case\">cT<\/jats:styled-content>1) correlated with <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content> activity score (\u03c1\u00a0=\u00a00.514, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.001). <jats:styled-content style=\"fixed-case\">cT<\/jats:styled-content>1, enhanced liver fibrosis (<jats:styled-content style=\"fixed-case\">ELF<\/jats:styled-content>) test and liver stiffness differentiated patients with simple steatosis and <jats:styled-content style=\"fixed-case\">NASH<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content> (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) of 0.69 (0.50\u20100.88), 0.87 (0.77\u20100.79) and 0.82 (0.70\u20100.94) respectively and healthy volunteers from patients with <jats:styled-content style=\"fixed-case\">AUROC<\/jats:styled-content> (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) of 0.93 (0.86\u20101.00), 0.81 (0.69\u20100.92) and 0.89 (0.77\u20101.00) respectively. For the risk stratification of <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content>, multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content> could save \u00a3150,218 per 1000 patients compared to biopsy. Multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content> did not discriminate between individual histological fibrosis stages in this population (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.068).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content> accurately identified patients with steatosis, stratifies those with <jats:styled-content style=\"fixed-case\">NASH<\/jats:styled-content> or simple steatosis and reliably excludes clinically significant liver disease with superior negative predictive value (83.3%) to liver stiffness (42.9%) and <jats:styled-content style=\"fixed-case\">ELF<\/jats:styled-content> (57.1%). For the risk stratification of <jats:styled-content style=\"fixed-case\">NAFLD<\/jats:styled-content>, multiparametric <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content> was cost effective and, combined with transient elastography, had the lowest cost per correct diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.14469","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T07:59:28Z","timestamp":1514102368000},"page":"631-644","source":"Crossref","is-referenced-by-count":96,"title":["Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non\u2010alcoholic fatty liver disease"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-7054","authenticated-orcid":false,"given":"P. J.","family":"Eddowes","sequence":"first","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Davies","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. I. K.","family":"Semple","sequence":"additional","affiliation":[{"name":"Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Kendall","sequence":"additional","affiliation":[{"name":"Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hodson","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-3652","authenticated-orcid":false,"given":"P. N.","family":"Newsome","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Flintham","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wesolowski","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Blake","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V.","family":"Duarte","sequence":"additional","affiliation":[{"name":"Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Herlihy","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Olliff","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"H\u00fcbscher","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-1471","authenticated-orcid":false,"given":"J. A.","family":"Fallowfield","sequence":"additional","affiliation":[{"name":"Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-2255","authenticated-orcid":false,"given":"G. M.","family":"Hirschfield","sequence":"additional","affiliation":[{"name":"Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.019984"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.04.014"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2004.04.004"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.027"},{"key":"e_1_2_7_9_1","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu IL","year":"2014","journal-title":"World J Gastroenterol"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.08.052"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.034"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.002"},{"key":"e_1_2_7_13_1","unstructured":"National Institute for Health and Care Excellence.Nonalcoholic fatty liver disease (NAFLD): assessment and management. NICE guidelines (NG49).2016."},{"key":"e_1_2_7_14_1","volume-title":"Cirrhosis in Over 16s: assessment and management. Nice guidelines (NG50)","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"e_1_2_7_15_1","unstructured":"BanerjeeR PiechnikS RobsonM et\u00a0al.Multi\u2010Parametric Magnetic Resonance Diagnosis & Staging of Liver Disease (US2014330106) 2014."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26455"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120896"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05121.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0177"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-131640"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25993"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.22579"},{"key":"e_1_2_7_25_1","first-page":"1","volume-title":"Tissue Pathways for Liver Biopsies for the Investigation of Medical Disease and for Focal Lesions","author":"Wyatt J","year":"2014"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22742"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700840107"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24268"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22745"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010507"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(08)74603-2"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12963"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12186"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.21809"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.016"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.021"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.009"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.203166"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14219"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13196"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13284"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1272836"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.14469","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.14469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T13:41:53Z","timestamp":1695044513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.14469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/apt.14469"],"URL":"https:\/\/doi.org\/10.1111\/apt.14469","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]}}}